Ammonia → HCID 68328565, compound
Reaction equation
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[N:13]=[C:12]([C:14]3[C:22]4[C:17](=[CH:18][CH:19]=[C:20]([C:23]5[S:24][C:25](S(C)(=O)=O)=[N:26][N:27]=5)[CH:21]=4)[N:16](C(OC(C)(C)C)=O)[CH:15]=3)[CH:11]=[CH:10][CH:9]=2)[CH2:4][CH2:3]1.[NH3:39].CCOC(C)=O>CS(C)=O>[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[N:13]=[C:12]([C:14]3[C:22]4[C:17](=[CH:18][CH:19]=[C:20]([C:23]5[S:24][C:25]([NH2:39])=[N:26][N:27]=5)[CH:21]=4)[NH:16][CH:15]=3)[CH:11]=[CH:10][CH:9]=2)[CH2:4][CH2:3]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 120 °C
Procedure
A sealed tube was charged with tert-butyl 3-(6-(4-methylpiperazin-1-yl)pyridin-2-yl)-5-(5-(methylsulfonyl)-1,3,4-thiadiazol-2-yl)-1H-indole-1-carboxylate (300 mg, 0.541 mmol) followed by ammonia in DMSO (10 mL). The reaction was heated at 120° C. for 4 h. Ice/H2O and EtOAc were added to the mixture. The organic layer was separated and the aqueous layer was extracted with EtOAc. The combined organic layer was dried, filtered and concentrated. The residue was purified with RP-HPLC to give 5-(3-(6-(4-methylpiperazin-1-yl)pyridin-2-yl)-1H-indol-5-yl)-1,3,4-thiadiazol-2-amine (40 mg, 19%). MS (ESI, pos. ion) m/z: 392.1 (M+1); 1H-NMR (DMSO-d6, 300 MHz) δ 11.76 (1H, s), 10 (1H, brs), 8.8 (1H, s), 8.16 (1H, s), 7.5-7.67 (4H, m), 7.28-7.3 (1H, d), 6.75-6.79 (1H, d), 4.54-4.57 (2H, d), 3.6-3.65 (2H, d), 3.17-3.24 (4H, m), 2.91 (3H, s).
Workup
- customThe organic layer was separated
- extractionthe aqueous layer was extracted with EtOAc
- customThe combined organic layer was dried
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified with RP-HPLC
Sources & evidence
- ORD record
- ord-3a22429923f04fa78830482686a664a4
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09321756B2
Reaction notes
Loading…